CIK 0001709941
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474721157
- Phone
- +1 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-10 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-06-05 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-09-27 | HEALY JAMES Director | Conversion | +1,638,236 | 1,638,236 | ||
| 2024-09-27 | HEALY JAMES Director | Purchase | +588,888 | $18.00 | $10.6M | 2,227,124 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +11,113 | $18.00 | $200K | 11,113 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +18,353 | $18.00 | $330K | 18,353 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +21,814 | $18.00 | $393K | 21,814 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +26,497 | $18.00 | $477K | 26,497 |
| 2024-09-27 | HEALY JAMES Director | Conversion · Series D Preferred Stock | −7,310,796 | 0 | ||
| 2024-09-25 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 1 of 1 · 10 trades